首页> 美国卫生研究院文献>BMC Nephrology >Evaluation of the efficacy of an interdialytic ethanol 40 v/v - enoxaparin 1000 U/mL lock solution to prevent tunnelled catheter infections in chronic hemodialysis patients: a multi-centre randomized single blind parallel group study
【2h】

Evaluation of the efficacy of an interdialytic ethanol 40 v/v - enoxaparin 1000 U/mL lock solution to prevent tunnelled catheter infections in chronic hemodialysis patients: a multi-centre randomized single blind parallel group study

机译:评估透析间使用 40%v / v乙醇-依诺肝素1000 U / mL锁定溶液在慢性血液透析患者中​​预防隧道感染的功效:一项多中心随机单盲平行组研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundTunnelled dialysis catheter (TC) infections are a major health complication and are associated with increased antibiotic consumption, hospital stays, health costs and mortality. Experimental data provide evidence that Ethenox, a mixture of enoxaparine 1000 U/mL in 40% v/v ethanol, could be a promising lock solution. The aim of the study is to compare an interdialytic lock solution of Ethenox with reference lock solutions, unfractionated heparin (UFH) or citrate 4% for the prevention of TCI in hemodialysis patients.
机译:背景隧道式透析导管(TC)感染是主要的健康并发症,与抗生素消耗量增加,住院时间,健康费用和死亡率有关。实验数据提供了证据,Ethenox是依诺肝素1000 U / mL在40%v / v乙醇中的混合物,可能是有前途的锁定解决方案。该研究的目的是将Ethenox的透析间锁液与参考锁液,普通肝素(UFH)或4%柠檬酸盐用于预防血液透析患者TCI的比较。

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号